MSB 1.57% 97.0¢ mesoblast limited

Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE, page-296

  1. 6,323 Posts.
    lightbulb Created with Sketch. 375
    So the Adcomm voted 8-3 against approval….so does this mean an imminent FDA approval ? An Adcomm voted 10-0 against approving a drug for AD….’death’ was a proven side effect…..however the FDA approved that AD drug !!!!!! We are truly at the mercy of an unpredictable bureaucratic beast.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.015(1.57%)
Mkt cap ! $1.073B
Open High Low Value Volume
96.0¢ 97.0¢ 91.5¢ $1.663M 1.776M

Buyers (Bids)

No. Vol. Price($)
22 15918 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 24733 8
View Market Depth
Last trade - 11.34am 29/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.